120 related articles for article (PubMed ID: 9890555)
1. Different early effets of tyrphostin AG957 and geldanamycins on mitogen-activated protein kinase and p120cbl phosphorylation in anti CD-3-stimulated T-lymphoblasts.
Losiewicz MD; Kaur G; Sausville EA
Biochem Pharmacol; 1999 Feb; 57(3):281-9. PubMed ID: 9890555
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of apoptosis by the tyrphostin AG957 in hematopoietic cells.
Urbano A; Gorgun G; Foss F
Biochem Pharmacol; 2002 Feb; 63(4):689-92. PubMed ID: 11992636
[TBL] [Abstract][Full Text] [Related]
3. Comparison of effects of the tyrosine kinase inhibitors AG957, AG490, and STI571 on BCR-ABL--expressing cells, demonstrating synergy between AG490 and STI571.
Sun X; Layton JE; Elefanty A; Lieschke GJ
Blood; 2001 Apr; 97(7):2008-15. PubMed ID: 11264165
[TBL] [Abstract][Full Text] [Related]
4. Tyrphostin AG957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores beta1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors.
Bhatia R; Munthe HA; Verfaillie CM
Leukemia; 1998 Nov; 12(11):1708-17. PubMed ID: 9823945
[TBL] [Abstract][Full Text] [Related]
5. Effects of the tyrosine kinase inhibitor AG957 and an Anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cells.
Carlo-Stella C; Regazzi E; Sammarelli G; Colla S; Garau D; Gazit A; Savoldo B; Cilloni D; Tabilio A; Levitzki A; Rizzoli V
Blood; 1999 Jun; 93(11):3973-82. PubMed ID: 10339507
[TBL] [Abstract][Full Text] [Related]
6. The Hsp90-specific inhibitor geldanamycin selectively disrupts kinase-mediated signaling events of T-lymphocyte activation.
Schnaider T; Somogyi J; Csermely P; Szamel M
Cell Stress Chaperones; 2000 Jan; 5(1):52-61. PubMed ID: 10701840
[TBL] [Abstract][Full Text] [Related]
7. CD38 ligation results in activation of the Raf-1/mitogen-activated protein kinase and the CD3-zeta/zeta-associated protein-70 signaling pathways in Jurkat T lymphocytes.
Zubiaur M; Izquierdo M; Terhorst C; Malavasi F; Sancho J
J Immunol; 1997 Jul; 159(1):193-205. PubMed ID: 9200455
[TBL] [Abstract][Full Text] [Related]
8. Tyrphostin induced growth inhibition: correlation with effect on p210bcr-abl autokinase activity in K562 chronic myelogenous leukemia.
Kaur G; Gazit A; Levitzki A; Stowe E; Cooney DA; Sausville EA
Anticancer Drugs; 1994 Apr; 5(2):213-22. PubMed ID: 8049505
[TBL] [Abstract][Full Text] [Related]
9. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
[TBL] [Abstract][Full Text] [Related]
10. Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway.
Schulte TW; Blagosklonny MV; Romanova L; Mushinski JF; Monia BP; Johnston JF; Nguyen P; Trepel J; Neckers LM
Mol Cell Biol; 1996 Oct; 16(10):5839-45. PubMed ID: 8816498
[TBL] [Abstract][Full Text] [Related]
11. Altered physical state of p210bcr-abl in tyrphostin AG957-treated K562 cells.
Kaur G; Sausville EA
Anticancer Drugs; 1996 Nov; 7(8):815-24. PubMed ID: 8991184
[TBL] [Abstract][Full Text] [Related]
12. Effects of the bcr/abl kinase inhibitors AG957 and NSC 680410 on chronic myelogenous leukemia cells in vitro.
Svingen PA; Tefferi A; Kottke TJ; Kaur G; Narayanan VL; Sausville EA; Kaufmann SH
Clin Cancer Res; 2000 Jan; 6(1):237-49. PubMed ID: 10656455
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization and sensitivity of STI-571 (imatinib mesylate, Gleevec)-resistant, Bcr-Abl-positive, human acute leukemia cells to SRC kinase inhibitor PD180970 and 17-allylamino-17-demethoxygeldanamycin.
Nimmanapalli R; O'Bryan E; Huang M; Bali P; Burnette PK; Loughran T; Tepperberg J; Jove R; Bhalla K
Cancer Res; 2002 Oct; 62(20):5761-9. PubMed ID: 12384536
[TBL] [Abstract][Full Text] [Related]
14. Alterations in the growth factor signal transduction pathways and modulators of the cell cycle in endocervical cells from macaques exposed to TCDD.
Enan E; El-Sabeawy F; Scott M; Overstreet J; Lasley B
Toxicol Appl Pharmacol; 1998 Aug; 151(2):283-93. PubMed ID: 9707505
[TBL] [Abstract][Full Text] [Related]
15. Effects of geldanamycin, a heat-shock protein 90-binding agent, on T cell function and T cell nonreceptor protein tyrosine kinases.
Yorgin PD; Hartson SD; Fellah AM; Scroggins BT; Huang W; Katsanis E; Couchman JM; Matts RL; Whitesell L
J Immunol; 2000 Mar; 164(6):2915-23. PubMed ID: 10706677
[TBL] [Abstract][Full Text] [Related]
16. Activation of Src-family tyrosine kinases during Fas-induced apoptosis.
Schlottmann KE; Gulbins E; Lau SM; Coggeshall KM
J Leukoc Biol; 1996 Oct; 60(4):546-54. PubMed ID: 8864141
[TBL] [Abstract][Full Text] [Related]
17. Uncoupling activation-dependent HS1 phosphorylation from nuclear factor of activated T cells transcriptional activation in Jurkat T cells: differential signaling through CD3 and the costimulatory receptors CD2 and CD28.
Hutchcroft JE; Slavik JM; Lin H; Watanabe T; Bierer BE
J Immunol; 1998 Nov; 161(9):4506-12. PubMed ID: 9794375
[TBL] [Abstract][Full Text] [Related]
18. Tyrosine phosphorylation of p120cbl in BCR/abl transformed hematopoietic cells mediates enhanced association with phosphatidylinositol 3-kinase.
Jain SK; Langdon WY; Varticovski L
Oncogene; 1997 May; 14(18):2217-28. PubMed ID: 9174058
[TBL] [Abstract][Full Text] [Related]
19. CD40 signaling pathway: anti-CD40 monoclonal antibody induces rapid dephosphorylation and phosphorylation of tyrosine-phosphorylated proteins including protein tyrosine kinase Lyn, Fyn, and Syk and the appearance of a 28-kD tyrosine phosphorylated protein.
Faris M; Gaskin F; Parsons JT; Fu SM
J Exp Med; 1994 Jun; 179(6):1923-31. PubMed ID: 7515102
[TBL] [Abstract][Full Text] [Related]
20. The linker phosphorylation site Tyr292 mediates the negative regulatory effect of Cbl on ZAP-70 in T cells.
Rao N; Lupher ML; Ota S; Reedquist KA; Druker BJ; Band H
J Immunol; 2000 May; 164(9):4616-26. PubMed ID: 10779765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
